Optimizing growth and brain development in preterm infants using a robotic device
Official title: Creating a CALMER NICU: Pilot Testing a Robot for Optimizing Growth and Brain Development in Preterm Infants in the NICU
Run by University of British Columbia · NCT04911452 · Data updated 2026-11-12
This study is testing a special therapy bed called Calmer to see if it helps reduce stress and improve growth and brain development in preterm babies in the NICU.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 26 Weeks to 30 Weeks |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Status | Recruiting |
| Started | September 27, 2021 |
| Main results expected | June 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | January 1, 2025 |
| Trial ID | NCT04911452 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are preterm infants born at 26-30 weeks gestational age who are admitted to the NICU and require respiratory support.
✕Probably not a fit
Patients with congenital anomalies, major neurological injuries, or ongoing infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot trial aims to assess the effectiveness of a prototype therapy bed called Calmer, designed to reduce stress in preterm infants in the neonatal intensive care unit (NICU). The device mimics skin-to-skin care by providing an artificial skin surface, heartbeat sounds, and breathing motion, personalized with recordings from the parents. The study will enroll preterm infants born at 26-30 weeks gestational age and will evaluate the feasibility of implementing this intervention, including patient accrual and adherence to treatment protocols. If successful, the results will inform a larger randomized controlled trial comparing the combined approach of skin-to-skin care and Calmer against skin-to-skin care alone.
Why it matters
Potential benefit: If successful, this approach could significantly improve brain development and reduce stress in preterm infants, leading to better long-term outcomes.
How similar studies have gone: Previous studies have shown promising results with similar approaches to reducing stress in preterm infants, indicating potential for success in this novel intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Preterm infants admitted to the neonatal intensive care unit (NICU) at the British Columbia (BC) Women's Hospital born at 26-30 completed weeks gestational age (GA). GA is determined accurately using early gestation ultrasonogram (standard of care in BC), or calculated using the last menstrual period; * Infants who are on continuous positive airway pressure or are ventilated; * At least one parent/caregiver must speak sufficient English to provide consent Exclusion Criteria: * Infants who have congenital anomalies, small for GA (per medical admission history), or have a history of maternal abuse of controlled drugs and substances; - Infants with an ongoing infection at the time of enrolment; * Infants that have pre-existing cardiovascular instability defined by shock/hypotension/need for cardiovascular drugs * Infants receiving paralytic drugs; * Infants that have major neurological injury (e.g. hypoxic ischemic encephalopathy, hemorrhage/stroke); * Infants who are beyond the 30th completed week GA (30 weeks + 6 days) at enrolment.
Where it's running
-
British Columbia Women's Hospital and Health Centre
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Liisa Holsti, PhD — The University of British Columbia
- Study coordinator: Manon Ranger, PhD
- Email: manon.ranger@ubc.ca
- Phone: 1-604-827-1382
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Household, wellbeing, and quality-of-life impacts of very preterm birth and necrotising enterocolitis
This project will collect information to see if pausing or continuing milk feeds around blood transfusions relates to babies' quality of life and the financial and emotional impact on families of very preterm infants, especially those with NEC.
-
Giving surfactant to premature infants using a thin catheter at birth
This study is testing if giving a special lung treatment to very premature babies right after birth using a thin tube can help them breathe better and need less breathing support in their first few days of life.
-
Earlier use of an electric breast pump to maximize milk in preterm babies
This study tests whether starting a double electric breast pump earlier (at birth) helps mothers of very preterm infants produce more milk by day 14.
-
Adding azithromycin to ampicillin for late PPROM
This test sees if adding a single dose of azithromycin to the usual ampicillin/amoxicillin treatment helps newborns when membranes break early between 34.0 and 36.6 weeks.
-
Medically tailored groceries to support pregnant people facing food insecurity
This project will test whether home-delivered medically tailored groceries, with or without extra food education, help Medicaid-eligible pregnant people in Cuyahoga County improve nutrition and birth outcomes.
-
Tracking intellectual and motor development in babies at high risk for cerebral palsy
This project will follow babies at higher risk for cerebral palsy to see if early thinking and movement signs predict later intellectual and motor outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.